Lixi F. Li

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with capecitabine in HER2-negative advanced breast cancer: a dose-escalation, phase I study.

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with capecitabine in HER2-negative advanced breast cancer: a dose-escalation, phase I study.

Journal: BMC medicine

Published: February 08, 2026

Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancer.

Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancer.

Journal: The oncologist

Published: September 05, 2025

Prognostic Models for Overall and Disease-Specific Survival in Palate Squamous Cell Carcinoma: Implications for Postoperative Radiotherapy.

Prognostic Models for Overall and Disease-Specific Survival in Palate Squamous Cell Carcinoma: Implications for Postoperative Radiotherapy.

Journal: Head & neck

Published: March 16, 2025

Investigating cardiovascular diseases related to endocrine therapy in hormone receptor-positive early breast cancer: insights from a nationwide real-world study.

Investigating cardiovascular diseases related to endocrine therapy in hormone receptor-positive early breast cancer: insights from a nationwide real-world study.

Journal: Cardio-oncology (London, England)

Published: February 06, 2025

Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population-Based Large Cohort Study.

Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population-Based Large Cohort Study.

Journal: Thoracic cancer

Published: January 01, 2025

Biologically-informed integration of drug representations for breast cancer treatment using deep learning.

Biologically-informed integration of drug representations for breast cancer treatment using deep learning.

Journal: Nature communications

Published: November 13, 2024

The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study.

The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study.

Journal: Breast (Edinburgh, Scotland)

Published: October 23, 2024

Efficacy of sutureless intrascleral intraocular lens fixation with the modified Yamane technique

Efficacy of sutureless intrascleral intraocular lens fixation with the modified Yamane technique

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: June 03, 2024

Genetic factors in the pathogenesis of cardio-oncology.

Genetic factors in the pathogenesis of cardio-oncology.

Journal: Journal of translational medicine

Published: April 07, 2024

Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: insights from the PHILA trial.

Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: insights from the PHILA trial.

Journal: EBioMedicine

Published: April 05, 2024

Efficacy and safety of first-line regimens for advanced HER2-positive breast cancer: A Bayesian network meta-analysis.

Efficacy and safety of first-line regimens for advanced HER2-positive breast cancer: A Bayesian network meta-analysis.

Journal: Cancer innovation

Published: January 11, 2024

PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives.

PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 16, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026